SlideShare a Scribd company logo
November 18, 2022
RADx® Underserved
Populations
RADx Underserved
Populations
(RADx-UP)
Understand and reduce the
disparities in COVID-19
morbidity and mortality for
those disproportionately
affected by COVID-19
This is us
BUDGET
$533 Million
RADxTech
Speed innovative point-of-
care, home-based, and
clinical laboratory tests for
COVID-19
BUDGET
$908 Million
RADx Advanced
Technology Platforms
(RADx-ATP)
Identify testing platforms
that are far enough advanced
for rapid scale-up or
expanded geographical
placement
BUDGET
$230 Million
RADx Radical
(RADx-rad)
Support new, non-
traditional approaches
to address current testing
gaps, and non-traditional
applications of existing
approaches
BUDGET
$187 Million
RADx-UP is Part of a $1.4 Billion NIH Initiative
RADx-UP is Community-Engaged Research
• Overarching goal is to evaluate strategies to increase uptake
and access to COVID-19 tests in underserved populations
• NIH started RADx-UP in September 2020, with awards in phases:
– Fall 2020: Phase 1 (69 projects) and CDCC
– Spring/Summer 2021: SayYes! COVIDTest and the Safe Return
to School DiagnosticTesting Initiative (16 projects)
– Fall/Winter 2021: Phase 2 (21 projects) and Supplemental (21 projects)
– Fall 2022: Additional Phase 3 projects expected
• RADx-UP projects build on existing community-academic
infrastructure, processes, and relationships
Take home messages
• The RADx-UP Coordination and Data Collection Center (CDCC) is a joint
collaboration of DCRI, UNC Chapel Hill, and the Community-Campus
Partnerships for Health. Started in September 2020.
• RADx-UP CDCC leverages the Secure Duke Azure Cloud
• We coordinate 135+ NIH funded projects and 40 funded pilot projects
• We are partnering with many communities throughout the country and use
data to drive and enhance those relationships
• Meetings: weekly with every project, project-wide every month, NIH every two
weeks, working groups, committees, hold scientific meetings, and organize an
annual equity evidence academy meeting
5
Program Overview
 Phase I: Established a consortium of community-engaged research projects focused primarily on
increasing access to and uptake of COVID-19 diagnostic testing
 Phase II: Expanded Phase I infrastructure, built in projects with an emphasis on interventions, including
a specific focus on school settings, and incorporated research to address vaccine hesitancy and
uptake
 Target Population: populations with health disparities, underserved and vulnerable groups
Overarching Goal
The overarching goal of RADx-UP is to understand factors that have led to the
disproportionate burden of the pandemic on underserved populations, so that COVID-
19 testing interventions can be developed and implemented to decrease these
disparities.
RADx-UP Phase I and II
RADx-UP Phase III
Leverage rapid, self-
administeredCOVID-19
testing to understand and
address COVID-19
morbidity and mortality
disparities among the
underserved and vulnerable
populations, given the
availability of COVID-19
vaccines
Study secondary impacts of
mandates for mitigation
measures associated with
COVID-19 and support
psychological and
communication science
interventions to improve
uptake of testing and
vaccination
Expand the evidence base of
scalable and sustainable
approaches to safely maintain
students in school. Integrate
new “Test-to-Stay” models that
reduce or avoid quarantine and
disruptions to the school
environment
TESTING SEBI SAFE IN SCHOOL
Goal: Address the evolving challenges of the pandemic with a focus on developing rapid testing
strategies for use with other mitigation efforts (e.g., vaccination, physical mitigation measures) to reduce
COVID-19 disparities.
Course of the Pandemic in the US
Case Rates for Vulnerable Populations
CDC COVID Data Tracker
Race/Ethnicity
https://covid.cdc.gov/covid-data-tracker/#demographicsovertime
alpha
delta
omicron
Death Rates for Vulnerable Populations
CDC COVID Data Tracker
Race/Ethnicity
https://covid.cdc.gov/covid-data-tracker/#demographicsovertime
alpha
delta
omicron
10
RADx-UP CDCC
Goals
Accelerate COVID-19 community implementation
implementation science via an agile, flexible,
flexible, participatory, transparent and sustainable
sustainable CDCC.
Support data collection, integration, and
integration, and sharing while preserving
preserving necessary data protections.
Amplify and disseminate community best practices
practices for successful implementation of COVID-
COVID-19 testing strategies and vaccines.
Utilize RADx-UP infrastructure to
support COVID-19 research.
11
Sept – Nov 2020
Phase I Phase II
Build
infrastructure
Rapidly
implement
testing, other
capabilities
Integrate
new
advances
Investigate social,
ethical, &
behavioral barriers
to testing
RADx-UP Phases and Timeline
Phase III
Expand
studies/
populations
2022
Overarching Goals
 Enhance COVID-19 testing among underserved and vulnerable populations across the US
 Develop/create a consortium of community-engaged research projects designed to rapidly implement testing interventions
 Strengthen the available data on disparities in infection rates, disease progression and outcomes, and identify strategies to reduce these
disparities in COVID-19 diagnostics
 Through better testing, RADx-UP will help researchers see a clearer picture of how COVID-19 affects these populations and how to improve
health outcomes around the virus
 Expand the evidence base of scalable and sustainable approaches to safely maintain students in school
Emphasis on
Rapid Testing
and Testing in
Schools
Jan – Nov 2021
School based
studies
Communities Served by RADx-UP Projects
13
Communities served by RADx-UP projects
Self-reported data reflects RADx-UP Phase I and II projects as of 10/20/2021
14
The RADx-UP Coordination
and Data Collection Center (CDCC)
 The CDCC serves as a hub for all RADx-UP funded projects.
 The CDCC supports RADx-UP projects to optimize engagement, outreach,
testing strategies, data collection and integration, and co-learning
opportunities between and among project teams and to the communities
that we serve.
 The CDCC is led by the Duke Clinical Research Institute (DCRI), and the
Center for Health Equity Research at UNC-Chapel Hill with support from
a key partner, Community-Campus Partnerships for Health.
15
 RADx-UP is the largest single NIH investment in understanding the factors
that protect or harm underserved communities.
 RADx-UP projects are required to collect the NIH RADx-UP Common Data
Elements (CDEs) in order to capture consistent data for comparison across
studies.
 The CDCC supports projects in aligning your activities with requirements to
make data findable, accessible, interoperable and reusable (FAIR).
 The RADx-UP aggregated data will be a resource for NIH, communities, and
researchers to understand the impact of COVID-19 on the well-being, risk,
resilience, and disparities in underserved and vulnerable communities.
NIH Vision for RADx-UP Data
The RADx-UP Coordination and Data Collection Center (CDCC)
Al Richmond, MSW
Community
Engagement Core
Community-Campus
Partnerships for Health
Susan Knox, MBA
CDCC Program Manager
Chris Woods, MD
COVID-19 Testing Core
Michael Cohen-
Wolkowiez,
MD, PhD
Duke Clinical Research
Institute (DCRI)
Principal Investigators
Giselle Corbie,
MD, MSc
UNC Center for Health
Equity Research
Warren A. Kibbe,
PhD, FACMI
Duke Department of
Biostatistics and
Bioinformatics
Core Leaders
100+ operational
& support staff
- Experienced
- Diversity of
backgrounds
and training
- Dedicated
Engagement Impact
Teams
Keith Marsolo, PhD
Data Science &
Biostatistics Core
Lisa Wruck, PhD
Data Science &
Biostatistics Core
Krista Perreira, PhD
Community
Engagement Core
Operations Key Partner
Al Richmond, MSW
Community-Campus
Partnerships for Health
17
RADx-UP CDCC - Guiding Principles
Communities are at the center of our work.
Data sovereignty protections, and sharing with communities
and participants, are essential in building trust and being
trustworthy.
Intentional support of study teams is critical to streamline
results and troubleshoot.
Broad dissemination of program activities, data, and best
practices are key.
Strategic partnerships will augment community benefits from
the program.
Impact will be broad and will inform national guidance, strategy,
and response to COVID-19.
18
Administration &
Coordination
 Communication
 Committee oversight
 Processes, policies,
procedures
 Partnerships
 Evaluation
Community
Engagement
 Best practices
 Engagement Resource
Library
 COVID-19 Equity
Evidence Academy
 Community of Practice
 Community
Collaboration Grants
COVID-19 Testing
 Technical support
 Repository of emerging
technologies
 Testing selection &
implementation
 Research pilot studies
Data Science &
Statistics
 Data harmonization
 Security, privacy, and
protections
 Data exchange
 Data representation and
visualization
ENGAGEMENT IMPACT TEAMS
CDCC Cores
RADx-UP CDCC Engagement ImpactTeams
• Single point-of-contact between CDCC and project teams with
project management & community engagement support
– Coordinating testing, community engagement, and data
collection and sharing resources
– Identifying challenges, collaboratively generating solutions,
sharing best practices
– Collecting required forms (data use agreements, IRB-approved
Informed Consent Forms, etc.)
– Connecting projects with translation services
– Monitoring progress
How CDCC and NIH collaborate to support projects
CDCC Engagement
ImpactTeams
• The primary point of
contact at CDCC for each
RADx-UP project
• Community engagement
and project management
NIH Project Officers
& Scientists
• Support in data forms and
grant-related questions
• First point of escalation
CDCC Informaticists
• Coordinate data uploads
by projects
• Perform quality reviews of
project data uploads
• EIT and PO/PS relationships are critical
to RADx-UP success
• EITs copy POs on messages to projects
• POs include EITs in communications
to projects
• When escalation is necessary,
EIT engages PO to facilitate
RADx-UP CDCC Community Engagement
• To date
– 450+ participants at COVID-19 Equity Evidence Academy events
– 20+ best practices/guidance documents
– 23 community collaboration grants
– 5+ channels for Community of Practice: Slack, newsletters,
meetings, CCPH consults, working groups
• Key CDCC lesson for this and future pandemics
– Deploying community-engaged projects during a pandemic requires
robust, trusted, and effective research-community partnerships
RADx-UPWorking Groups
• RADx-UP projects meet to tackle
topics and challenges that may
commonly occur among similar
populations across the country
• Recently added: Social, Ethical and
Behavioral ImplicationsWorking
Group
is gr7306@comcast.net.
Project publications on RADx-UP.org
Highlighting
RADx-UP
publications with
research briefs,
blog posts, video
explainers, and
more
RADx-UP Resources
• CDCC continues to collect and create resources
for community-engaged researchers and
community partners
• 132 resources in the collection
• Search by
– Audience
– Topic
– Resource type
• Start at https://radx-up.org/resources/RADx-UP
Strategies from the RADx-UP Initiative
• A new policy framework based on
experiences from RADx-UP project teams
• Identifies 5 key actions to address health
inequities in COVID-19 and beyond
• Learn more at
https://radx-up.org/research/health-equity-
framework/
Analysis Concepts & Proposals
• Initiative to support the preparation of
collaborative research articles and
presentations that analyze RADx-UP data.
• Consortium members are collaborating in
writing teams with CDCC statistical
support.
• Their publications will help community
leaders and policy makers identify effective
strategies for reducing disparities in COVID-
19 testing and addressing other health
needs of their communities.
2021
MAY
OCT NOV DEC JAN FEB MAR APR
SEP JUN
2022
RADx-UP Key Milestones: Sept. 2021–June 2022
12/2021
Launch of RADx-UP
Colectiv data capture tool
12/1/2021
NEW Community
Consultation
Studio Sessions
1 4
1 2 4
10/2021
RADx-UP Data
Quality Resolution
Policy and Process
1/20/2022
Guidance and Testing Information
re: Delta/Omicron surges
Launch of RADx-UP
Community
Connections Series
10/21/2021
RADx-UP
Scientific
Meeting
11/2021
Guidance and Testing
Information re Ellume
home test recall
NIH RADx-UP CDEs
v1.2 in Spanish
11/17–11/18/2021
RADx-UP COVID-19
Equity Evidence Academy
11/18/2021
You & Me COVID-Free
Program
1 2 3 4
1 2 3 4
1 2 3 4
1 3
1 2 4
1 2 4
1 4
1 2 3
1/2022
RADx-UP Image Bank
Orientation Session
1 2
5/16/2022
RADx-UP Partnering
for Impact
1 4
5/11/2022
RADx-UP Health
Equity Policy
Framework
1 2 3 4
5/3/2022
RADx-UP Scientific
Meeting
1 2 3 4
4/6/2022
NIH RADx-UP
CDEs v1.5
1 4
2/3/2022
Webinar: A Community Engaged
Approach to COVID-19 Testing in
African-American Churches
1 2 3 4
2/14/2022
CDCC New Project
Orientation Session
1 2 3 4
2/17/2022
Engaging Black/
African American Working
Group virtual town hall
1 2 3 4
2/28/2022
67 projects uploaded CDE data to CDCC
4
3/10/2022
RADx-UP Data Dashboard
1 4
3/17/2022
RADx-UP Area-Level
Data Linkage Dashboard
1 4
3/25/2022
RADx-UP.org Redesign
1 2 3 4
Create a community-centered, flexible program infrastructure.
Support a participatory and inclusive community engagement program.
Support research projects with COVID-19 testing guidance and emerging science.
Collect, harmonize, integrate and disseminate data to scientific and local communities.
SPECIFIC
AIMS:
1
2
3
4
4/7/2022
First Data
Transfer to
RADx Data Hub
(data from 2
projects)
4
6/9/2022
Second Transfer to
RADx Data Hub
(data from 53 projects)
4
⭐️
⭐️
⭐️
⭐️
Data as of 10/18/2022
at a glance
49
CommunityCollaboration
Mini Grants
127
COVID-19 testing
and SEBI projects
113
Published
research articles
56
States, territories,
and D.C.
1
Coordination & Data
Collection Center
>319,000
Enrolled participants
(prospectively)
16
Rapid Research
Pilot Awards
86
Projects submitting
CDEs to CDCC
>389,000
COVID-19 tests conducted
(prospectively)
29
Key Outcomes per Target Population (Testing + SEBI)
Schools
 Participation in weekly testing increases
conscious mitigation behavior
 When mitigation strategies are followed,
in-school transmission is low (<1%)
Black and Latino Communities
 Latino populations present with greater proportions
of asymptomatic cases as compared to national
average
 Black/African Americans in rural areas have lower
testing rates, biasing positivity rates
 Black and Latino community populations display
greater vaccine hesitancy – Local leaders should
be engaged to facilitate acceptance and uptake
Lower Socioeconomic
Status
 Lower income populations have
reduced motivation to self-test and
distribute testing kits to contacts
Common Data Elements Development, Evolution,
Implementation and Lessons Learned
CDE Development
• Oct. 9, 2020: NIH’s RADx-UP Data Harmonization Guidance received by CDCC, which
included the original RADx-UP Common Data Elements
• Oct. 16, 2020: CDCC team met with the DR2 team to discuss coordination and the CDEs
• Based on initial discussions with NIH RADx-UP leadership, it became clear that the
original CDEs needed to be modified to meet the project and pandemic circumstances:
– Staff and participants were practicing social distancing, with masks
– Vaccines were in development but not yet available
– Moving into winter 2020, with a surge in cases and deaths expected
– Many of the Projects had finalized their protocols and were awaiting IRB approval
• CDEs needed to collect key data while also limiting risk and burden for the
participants and Project teams
CDE Development
• Oct. & Nov. 2020: CDCC and NIH worked to revise and pare down the
number of CDEs
• Dec. 3, 2020: draft version of the CDEs shared with the projects
RADx-UPCDE Categories
• Sociodemographics and consent
• Housing, Employment and Insurance
• Medical History
• Medications
• Symptoms
• Health Status (includingAlcohol andTobacco)
• Disability
• Vaccine Hesitancy
• Identity
CDE Development
• Dec. 8, 2020: CDE Feedback survey sent to the Projects
• Dec 14, 2020: Deadline for Projects to complete the survey
• Dec. 15, 2020: CDCC reviewed and consolidated feedback and
recommendations
• Dec. 17, 2020: RADx-UP Project-wide Meeting at which
CDE feedback was discussed
13
52
Feedback Survey Questions and Results (Dec 2020)
31
10
7 8
25
9 8
19 18
22
42
8
0
5
10
15
20
25
30
35
40
45
Identity Consent Symptoms
(COVID-19)
Demographics Disability Employment Health
Insurance
Health Status Housing Medical History Medications Vaccine
Hesitancy
Which category or categories contain
questions you anticipate not being able
to collect?
CDE Development
• Dec. 18, 2020 – Jan. 2021: CDCC and NIH incorporate Project feedback
and finalize the CDEs. Major changes included:
– Ethnicity (subcategories added for Asian, Native Hawaiian/Pacific Islander, and Hispanic),
– Sexual orientation and gender identity questions added and terminology better aligned with
communities
– Housing questions clarified and made more relevant to RADx-UP populations
– Employment questions made more relevant to COVID-19 pandemic conditions
– Health insurance question expanded to include type of insurance
– COVID-19 pandemic-related questions added (hardship, PPE, distancing, COVID testing,
COVID symptoms, vaccine acceptance)
– Spoken language questions added
– Medical history questions focused on items relevant to COVID-19
– Medications, vaccine hesitancy, and most of the disability and alcohol/tobaccos questions
were moved toTier 2.
Sources of these CDEs included PhenX, DR2, NIH CDE Repository, and the RADx-UP Projects
Tier 1 CDEs
Required from
all testing
Projects
• Consent
• Location (new)
• Sociodemographics
• Housing, Employment and
Insurance
• Work PPE and Distancing (new)
• Medical History
• Health Status
• VaccineAcceptance
• Testing (new)
• COVIDTest (new)
• Symptoms
• Alcohol &Tobacco
• Identity
Tier 2 CDEs
Recommended
additionalCDEs
• Sociodemographics
• Medical History
• VaccineAcceptance
• Testing
• Medications
• Alcohol andTobacco
• Drug Use
• Disability
• Food Insecurity
• Housing
• Trust
• Identity – SSN and MRN
• Two components:
• CDEs recorded by the participants or Project teams
• CDEs recorded by the Project teams
• Available as REDCap codebook PDF or CSV data dictionary, or PDF forms for paper data collection
CDE Development
• Jan. 4, 2021: CDEs v.1.0 released to the Projects and
made publicly available on RADx-UP.org
• Feb. 9-17, 2021: NIH CDETracking Form released,
which the Projects could use to request individual or
group CDE exceptions and wording changes.
• Feb. 2021: CDCC’s Data Submission Guidance
document v1.0 released.
• EITs and Informaticists began training and providing
support for CDE implementation.
CDE Revisions
Version Release Date Major Changes
1.1 Aug. 12, 2021 Wording, responses, and branching logic fixes
1.2 Sep. 28, 2021 Added vaccine acceptance and administration questions
1.3 Incorporated into 1.4
1.4 Feb. 9, 2022 Added “prefer not to answer” to more questions, existing CDEs
modified for pediatric use, and new Pediatric CDEs
1.5 Apr. 6, 2022 Wording, responses, and branching logic fixes
1.6 Oct. 27, 2022 Additional disability questions moved toTier 1
Any new or revisedTier 1 CDEs are only required for projects that were awarded after the CDE release date
CDE Intake and Quality Checks
• The REDCap codebooks along with the NIH CDE
Tracking Form have been the basis around which we
have built our repository, data quality and
conformance checks, reporting and dashboards, and
analysis datasets.
• Projects upload their data through our portal
(myRADx-Uphome) and get immediate, detailed
data quality reports that they use to identify and
resolve issues in their CDE data.
RADx-UP Data Intake Status
• As of Nov 1, 2022:
– 99 Projects have uploaded CDE data files
– 641,404 participants’ data in our database (not including EHR data)
– Using 5,310 project participants’ zip codes, the CDCC has linked to
external social determinants of health datasets:
Area deprivation index (ADI)
Agency for Healthcare Research and Quality (AHRQ)
SocialVulnerability Index (SVI)
ChildOpportunity Index (COI)
PandemicVulnerability Index (PVI)
Minority Health SVI
vaccination data from cdc.gov
Benefits of the RADx-UP CDEs
• The CDEs allowed for accelerated intake, harmonization, and use of data:
– January 2021: CDEs released
– March 2021: First data upload to CDCC
– March 2022: RADx-UP Data Dashboard launched (visualizations using CDE data)
– April 2022: First data upload from CDCC to the RADx Data Hub
– September 2022: Core Analytic Datasets available usingTier 1 CDE data
– October 2022: First consortia datasets delivered to writing team for analysis
• For the most part, projects were able to quickly understand and resolve data
quality and conformance issues. After a few uploads the number of data issues
drop significantly.
• We have given all newer versions of a CDE its own identifier, so we can trace
exactly which version of a CDE was given to a participant and allow projects to
update to new versions of the CDEs on their own timeline.
43
To date:
•NIH, CDCC, and RADx-UP (Phase I) projects collaborated to
develop the NIH RADx-UP Common Data Elements, from 700+ →
60+
•Currently, 99 projects are transferring study data and RADx-UP
NIH CDEs to the CDCC data repository
•CDE Dashboard provides a window to the aggregated data, will
inform consortium publications
Key CDCC lesson for this and future pandemics
•Developing CDEs during a pandemic is challenging
•Engaging projects and community partners is critical to
success
RADx-UP CDCC Data Science & Biostatistics Core
RADx-UP Dashboards
CDE Utilization: RADx-UP CDE Data Dashboard
This
Dashboard is
an example of
what’s been
possible using
the
harmonized
CDE data.
Periodic DataWorkshops
RADx-UP CDE Data Journey
CDE and Data ManagementTakeaways
• For community-engaged research, bidirectional communication and
collaboration between researchers, communities, and participants helps
with understanding, acceptance, and uptake of CDEs
• Collaboration also ensures that the CDEs accurately reflect the people
and communities who are taking part in the research
• Participant and study staff burden and risk are important concerns for
data collection in a pandemic
• CDEs are the foundation – however ingesting data from multiple
independent projects with many different experimental designs and
scientific goals still requires robust data quality and conformance
training, education, monitoring, and review processes
• For encouraging testing and vaccination, culturally appropriate
education is important to increase trust in official sources of
COVID-19 information
• Community Advisory Boards have provided key
recommendations and support
• Community engagement and trust are essential to ensure the
success of COVID-19 testing and vaccination programs
• Flexibility and the ability to adapt is critical
• Partnerships with community health clinics provide a
necessary connection to underserved populations
Lessons Learned for Future Success
Thank you.
Warren Kibbe
warren.kibbe@duke.edu

More Related Content

Similar to RADx-UP CDCC Overview November 2022

Community HIV Program Indicators
Community HIV Program IndicatorsCommunity HIV Program Indicators
Community HIV Program Indicators
MEASURE Evaluation
 
Nacp iv ppt
Nacp iv pptNacp iv ppt
Nacp iv ppt
Meely Panda
 
Promoting Innovation and evidenced based approaches to policy makers
Promoting Innovation and evidenced based approaches to policy makersPromoting Innovation and evidenced based approaches to policy makers
Promoting Innovation and evidenced based approaches to policy makers
Ted Herbosa
 
MNM COVID-19 Study
MNM COVID-19 StudyMNM COVID-19 Study
MNM COVID-19 Study
Michael Fritz
 
Digital transformation to enable a FAIR approach for health data science
Digital transformation to enable a FAIR approach for health data scienceDigital transformation to enable a FAIR approach for health data science
Digital transformation to enable a FAIR approach for health data science
Varsha Khodiyar
 
Public deck
Public deckPublic deck
Public deck
Michael Klein
 
Clinical Research Informatics Year-in-Review 2021
Clinical Research Informatics Year-in-Review 2021Clinical Research Informatics Year-in-Review 2021
Clinical Research Informatics Year-in-Review 2021
Peter Embi
 
Operational research
Operational researchOperational research
Operational research
jyotinayak44
 
21st Century Approaches to Risk Sciences
21st Century Approaches to Risk Sciences21st Century Approaches to Risk Sciences
21st Century Approaches to Risk Sciences
Christina Parmionova
 
Taking Collaborations to Scale to Improve Population Health
Taking Collaborations to Scale to Improve Population HealthTaking Collaborations to Scale to Improve Population Health
Taking Collaborations to Scale to Improve Population Health
Practical Playbook
 
ANALYZING THE EFFECTS OF DIFFERENT POLICIES AND STRICTNESS LEVELS ON MONTHLY ...
ANALYZING THE EFFECTS OF DIFFERENT POLICIES AND STRICTNESS LEVELS ON MONTHLY ...ANALYZING THE EFFECTS OF DIFFERENT POLICIES AND STRICTNESS LEVELS ON MONTHLY ...
ANALYZING THE EFFECTS OF DIFFERENT POLICIES AND STRICTNESS LEVELS ON MONTHLY ...
IJDKP
 
Lessons from the UK: Data access, patient trust & real-world impact with heal...
Lessons from the UK: Data access, patient trust & real-world impact with heal...Lessons from the UK: Data access, patient trust & real-world impact with heal...
Lessons from the UK: Data access, patient trust & real-world impact with heal...
Varsha Khodiyar
 
Rare Disease Patient Registries: Key to Drug Development and Access Webinar ...
Rare Disease Patient Registries:  Key to Drug Development and Access Webinar ...Rare Disease Patient Registries:  Key to Drug Development and Access Webinar ...
Rare Disease Patient Registries: Key to Drug Development and Access Webinar ...
Canadian Organization for Rare Disorders
 
EuroBioForum 2013 - Day 1 | Etienne Richer
EuroBioForum 2013 - Day 1 | Etienne RicherEuroBioForum 2013 - Day 1 | Etienne Richer
EuroBioForum 2013 - Day 1 | Etienne Richer
EuroBioForum
 
Global Globin 2020 Challenge: Developing capacity for gene variant data shari...
Global Globin 2020 Challenge: Developing capacity for gene variant data shari...Global Globin 2020 Challenge: Developing capacity for gene variant data shari...
Global Globin 2020 Challenge: Developing capacity for gene variant data shari...
Human Variome Project
 
A VIVO VIEW OF CANCER RESEARCH: Dream, Vision and Reality
A VIVO VIEW OF CANCER RESEARCH: Dream, Vision and RealityA VIVO VIEW OF CANCER RESEARCH: Dream, Vision and Reality
A VIVO VIEW OF CANCER RESEARCH: Dream, Vision and Reality
Paul Courtney
 
How Community Engagement Fits Into The Mission Of The National Center for Adv...
How Community Engagement Fits Into The Mission Of The National Center for Adv...How Community Engagement Fits Into The Mission Of The National Center for Adv...
How Community Engagement Fits Into The Mission Of The National Center for Adv...
SC CTSI at USC and CHLA
 
The IMI EHDEN project: large-scale analysis of observation data in Europe - C...
The IMI EHDEN project: large-scale analysis of observation data in Europe - C...The IMI EHDEN project: large-scale analysis of observation data in Europe - C...
The IMI EHDEN project: large-scale analysis of observation data in Europe - C...
Maxim Moinat
 
Global Financing Facility (GFF) in Support of Every Woman Every Child Worksho...
Global Financing Facility (GFF) in Support of Every Woman Every Child Worksho...Global Financing Facility (GFF) in Support of Every Woman Every Child Worksho...
Global Financing Facility (GFF) in Support of Every Woman Every Child Worksho...
Global Financing Facility in support of Every Woman Every Child
 
The FDA Digital Health Center of Excellence and the Advancement of Digital He...
The FDA Digital Health Center of Excellence and the Advancement of Digital He...The FDA Digital Health Center of Excellence and the Advancement of Digital He...
The FDA Digital Health Center of Excellence and the Advancement of Digital He...
Greenlight Guru
 

Similar to RADx-UP CDCC Overview November 2022 (20)

Community HIV Program Indicators
Community HIV Program IndicatorsCommunity HIV Program Indicators
Community HIV Program Indicators
 
Nacp iv ppt
Nacp iv pptNacp iv ppt
Nacp iv ppt
 
Promoting Innovation and evidenced based approaches to policy makers
Promoting Innovation and evidenced based approaches to policy makersPromoting Innovation and evidenced based approaches to policy makers
Promoting Innovation and evidenced based approaches to policy makers
 
MNM COVID-19 Study
MNM COVID-19 StudyMNM COVID-19 Study
MNM COVID-19 Study
 
Digital transformation to enable a FAIR approach for health data science
Digital transformation to enable a FAIR approach for health data scienceDigital transformation to enable a FAIR approach for health data science
Digital transformation to enable a FAIR approach for health data science
 
Public deck
Public deckPublic deck
Public deck
 
Clinical Research Informatics Year-in-Review 2021
Clinical Research Informatics Year-in-Review 2021Clinical Research Informatics Year-in-Review 2021
Clinical Research Informatics Year-in-Review 2021
 
Operational research
Operational researchOperational research
Operational research
 
21st Century Approaches to Risk Sciences
21st Century Approaches to Risk Sciences21st Century Approaches to Risk Sciences
21st Century Approaches to Risk Sciences
 
Taking Collaborations to Scale to Improve Population Health
Taking Collaborations to Scale to Improve Population HealthTaking Collaborations to Scale to Improve Population Health
Taking Collaborations to Scale to Improve Population Health
 
ANALYZING THE EFFECTS OF DIFFERENT POLICIES AND STRICTNESS LEVELS ON MONTHLY ...
ANALYZING THE EFFECTS OF DIFFERENT POLICIES AND STRICTNESS LEVELS ON MONTHLY ...ANALYZING THE EFFECTS OF DIFFERENT POLICIES AND STRICTNESS LEVELS ON MONTHLY ...
ANALYZING THE EFFECTS OF DIFFERENT POLICIES AND STRICTNESS LEVELS ON MONTHLY ...
 
Lessons from the UK: Data access, patient trust & real-world impact with heal...
Lessons from the UK: Data access, patient trust & real-world impact with heal...Lessons from the UK: Data access, patient trust & real-world impact with heal...
Lessons from the UK: Data access, patient trust & real-world impact with heal...
 
Rare Disease Patient Registries: Key to Drug Development and Access Webinar ...
Rare Disease Patient Registries:  Key to Drug Development and Access Webinar ...Rare Disease Patient Registries:  Key to Drug Development and Access Webinar ...
Rare Disease Patient Registries: Key to Drug Development and Access Webinar ...
 
EuroBioForum 2013 - Day 1 | Etienne Richer
EuroBioForum 2013 - Day 1 | Etienne RicherEuroBioForum 2013 - Day 1 | Etienne Richer
EuroBioForum 2013 - Day 1 | Etienne Richer
 
Global Globin 2020 Challenge: Developing capacity for gene variant data shari...
Global Globin 2020 Challenge: Developing capacity for gene variant data shari...Global Globin 2020 Challenge: Developing capacity for gene variant data shari...
Global Globin 2020 Challenge: Developing capacity for gene variant data shari...
 
A VIVO VIEW OF CANCER RESEARCH: Dream, Vision and Reality
A VIVO VIEW OF CANCER RESEARCH: Dream, Vision and RealityA VIVO VIEW OF CANCER RESEARCH: Dream, Vision and Reality
A VIVO VIEW OF CANCER RESEARCH: Dream, Vision and Reality
 
How Community Engagement Fits Into The Mission Of The National Center for Adv...
How Community Engagement Fits Into The Mission Of The National Center for Adv...How Community Engagement Fits Into The Mission Of The National Center for Adv...
How Community Engagement Fits Into The Mission Of The National Center for Adv...
 
The IMI EHDEN project: large-scale analysis of observation data in Europe - C...
The IMI EHDEN project: large-scale analysis of observation data in Europe - C...The IMI EHDEN project: large-scale analysis of observation data in Europe - C...
The IMI EHDEN project: large-scale analysis of observation data in Europe - C...
 
Global Financing Facility (GFF) in Support of Every Woman Every Child Worksho...
Global Financing Facility (GFF) in Support of Every Woman Every Child Worksho...Global Financing Facility (GFF) in Support of Every Woman Every Child Worksho...
Global Financing Facility (GFF) in Support of Every Woman Every Child Worksho...
 
The FDA Digital Health Center of Excellence and the Advancement of Digital He...
The FDA Digital Health Center of Excellence and the Advancement of Digital He...The FDA Digital Health Center of Excellence and the Advancement of Digital He...
The FDA Digital Health Center of Excellence and the Advancement of Digital He...
 

More from Warren Kibbe

CCDI Kibbe Wake Forest University Dec 2023.pptx
CCDI Kibbe Wake Forest University Dec 2023.pptxCCDI Kibbe Wake Forest University Dec 2023.pptx
CCDI Kibbe Wake Forest University Dec 2023.pptx
Warren Kibbe
 
Big Data Training for Cancer Research, Purdue, May 2023
Big Data Training for Cancer Research, Purdue, May 2023Big Data Training for Cancer Research, Purdue, May 2023
Big Data Training for Cancer Research, Purdue, May 2023
Warren Kibbe
 
CCDI Overview November 2022
CCDI Overview November 2022CCDI Overview November 2022
CCDI Overview November 2022
Warren Kibbe
 
CCDI Kibbe Big Data Training May 2022
CCDI Kibbe Big Data Training May 2022CCDI Kibbe Big Data Training May 2022
CCDI Kibbe Big Data Training May 2022
Warren Kibbe
 
Real world data, the National COVID-19 Cohort Consortium, and Oncology 2021
Real world data, the National COVID-19 Cohort Consortium, and Oncology 2021Real world data, the National COVID-19 Cohort Consortium, and Oncology 2021
Real world data, the National COVID-19 Cohort Consortium, and Oncology 2021
Warren Kibbe
 
Childhood Cancer Data Initiative presentation to the Children’s Brain Tumor N...
Childhood Cancer Data Initiative presentation to the Children’s Brain Tumor N...Childhood Cancer Data Initiative presentation to the Children’s Brain Tumor N...
Childhood Cancer Data Initiative presentation to the Children’s Brain Tumor N...
Warren Kibbe
 
DCHI webinar on N3C January 2021
DCHI webinar on N3C January 2021DCHI webinar on N3C January 2021
DCHI webinar on N3C January 2021
Warren Kibbe
 
NCATS CTSA N3C
NCATS CTSA N3C NCATS CTSA N3C
NCATS CTSA N3C
Warren Kibbe
 
NAACCR June 2020
NAACCR June 2020NAACCR June 2020
NAACCR June 2020
Warren Kibbe
 
NCI HTAN, cancer trajectories, precision oncology
NCI HTAN, cancer trajectories, precision oncologyNCI HTAN, cancer trajectories, precision oncology
NCI HTAN, cancer trajectories, precision oncology
Warren Kibbe
 
ENAR 2020
ENAR 2020ENAR 2020
ENAR 2020
Warren Kibbe
 
ENAR 2020
ENAR 2020ENAR 2020
ENAR 2020
Warren Kibbe
 
Technology and connected health for population science kibbe duke jan 2020
Technology and connected health for population science kibbe duke jan 2020Technology and connected health for population science kibbe duke jan 2020
Technology and connected health for population science kibbe duke jan 2020
Warren Kibbe
 
Super computing 19 Cancer Computing Workshop Keynote
Super computing 19 Cancer Computing Workshop KeynoteSuper computing 19 Cancer Computing Workshop Keynote
Super computing 19 Cancer Computing Workshop Keynote
Warren Kibbe
 
Data Harmonization for a Molecularly Driven Health System
Data Harmonization for a Molecularly Driven Health SystemData Harmonization for a Molecularly Driven Health System
Data Harmonization for a Molecularly Driven Health System
Warren Kibbe
 
Data supporting precision oncology fda wakibbe
Data supporting precision oncology fda wakibbeData supporting precision oncology fda wakibbe
Data supporting precision oncology fda wakibbe
Warren Kibbe
 
Role of data in precision oncology
Role of data in precision oncologyRole of data in precision oncology
Role of data in precision oncology
Warren Kibbe
 
Data Harmonization for a Molecularly Driven Health System
Data Harmonization for a Molecularly Driven Health SystemData Harmonization for a Molecularly Driven Health System
Data Harmonization for a Molecularly Driven Health System
Warren Kibbe
 
Data sharing Webinar March 2019
Data sharing Webinar March  2019Data sharing Webinar March  2019
Data sharing Webinar March 2019
Warren Kibbe
 
Data in precision oncology SAMSI Precision Medicine Meeting mar 2019
Data in precision oncology SAMSI Precision Medicine Meeting mar 2019Data in precision oncology SAMSI Precision Medicine Meeting mar 2019
Data in precision oncology SAMSI Precision Medicine Meeting mar 2019
Warren Kibbe
 

More from Warren Kibbe (20)

CCDI Kibbe Wake Forest University Dec 2023.pptx
CCDI Kibbe Wake Forest University Dec 2023.pptxCCDI Kibbe Wake Forest University Dec 2023.pptx
CCDI Kibbe Wake Forest University Dec 2023.pptx
 
Big Data Training for Cancer Research, Purdue, May 2023
Big Data Training for Cancer Research, Purdue, May 2023Big Data Training for Cancer Research, Purdue, May 2023
Big Data Training for Cancer Research, Purdue, May 2023
 
CCDI Overview November 2022
CCDI Overview November 2022CCDI Overview November 2022
CCDI Overview November 2022
 
CCDI Kibbe Big Data Training May 2022
CCDI Kibbe Big Data Training May 2022CCDI Kibbe Big Data Training May 2022
CCDI Kibbe Big Data Training May 2022
 
Real world data, the National COVID-19 Cohort Consortium, and Oncology 2021
Real world data, the National COVID-19 Cohort Consortium, and Oncology 2021Real world data, the National COVID-19 Cohort Consortium, and Oncology 2021
Real world data, the National COVID-19 Cohort Consortium, and Oncology 2021
 
Childhood Cancer Data Initiative presentation to the Children’s Brain Tumor N...
Childhood Cancer Data Initiative presentation to the Children’s Brain Tumor N...Childhood Cancer Data Initiative presentation to the Children’s Brain Tumor N...
Childhood Cancer Data Initiative presentation to the Children’s Brain Tumor N...
 
DCHI webinar on N3C January 2021
DCHI webinar on N3C January 2021DCHI webinar on N3C January 2021
DCHI webinar on N3C January 2021
 
NCATS CTSA N3C
NCATS CTSA N3C NCATS CTSA N3C
NCATS CTSA N3C
 
NAACCR June 2020
NAACCR June 2020NAACCR June 2020
NAACCR June 2020
 
NCI HTAN, cancer trajectories, precision oncology
NCI HTAN, cancer trajectories, precision oncologyNCI HTAN, cancer trajectories, precision oncology
NCI HTAN, cancer trajectories, precision oncology
 
ENAR 2020
ENAR 2020ENAR 2020
ENAR 2020
 
ENAR 2020
ENAR 2020ENAR 2020
ENAR 2020
 
Technology and connected health for population science kibbe duke jan 2020
Technology and connected health for population science kibbe duke jan 2020Technology and connected health for population science kibbe duke jan 2020
Technology and connected health for population science kibbe duke jan 2020
 
Super computing 19 Cancer Computing Workshop Keynote
Super computing 19 Cancer Computing Workshop KeynoteSuper computing 19 Cancer Computing Workshop Keynote
Super computing 19 Cancer Computing Workshop Keynote
 
Data Harmonization for a Molecularly Driven Health System
Data Harmonization for a Molecularly Driven Health SystemData Harmonization for a Molecularly Driven Health System
Data Harmonization for a Molecularly Driven Health System
 
Data supporting precision oncology fda wakibbe
Data supporting precision oncology fda wakibbeData supporting precision oncology fda wakibbe
Data supporting precision oncology fda wakibbe
 
Role of data in precision oncology
Role of data in precision oncologyRole of data in precision oncology
Role of data in precision oncology
 
Data Harmonization for a Molecularly Driven Health System
Data Harmonization for a Molecularly Driven Health SystemData Harmonization for a Molecularly Driven Health System
Data Harmonization for a Molecularly Driven Health System
 
Data sharing Webinar March 2019
Data sharing Webinar March  2019Data sharing Webinar March  2019
Data sharing Webinar March 2019
 
Data in precision oncology SAMSI Precision Medicine Meeting mar 2019
Data in precision oncology SAMSI Precision Medicine Meeting mar 2019Data in precision oncology SAMSI Precision Medicine Meeting mar 2019
Data in precision oncology SAMSI Precision Medicine Meeting mar 2019
 

Recently uploaded

Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
ShashankRoodkee
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Colonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implicationsColonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implications
Dr Maria Tamanna
 
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptxSURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
Bright Chipili
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
SwastikAyurveda
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAdv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
AkankshaAshtankar
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 

Recently uploaded (20)

Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Colonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implicationsColonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implications
 
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptxSURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAdv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 

RADx-UP CDCC Overview November 2022

  • 1. November 18, 2022 RADx® Underserved Populations
  • 2. RADx Underserved Populations (RADx-UP) Understand and reduce the disparities in COVID-19 morbidity and mortality for those disproportionately affected by COVID-19 This is us BUDGET $533 Million RADxTech Speed innovative point-of- care, home-based, and clinical laboratory tests for COVID-19 BUDGET $908 Million RADx Advanced Technology Platforms (RADx-ATP) Identify testing platforms that are far enough advanced for rapid scale-up or expanded geographical placement BUDGET $230 Million RADx Radical (RADx-rad) Support new, non- traditional approaches to address current testing gaps, and non-traditional applications of existing approaches BUDGET $187 Million RADx-UP is Part of a $1.4 Billion NIH Initiative
  • 3. RADx-UP is Community-Engaged Research • Overarching goal is to evaluate strategies to increase uptake and access to COVID-19 tests in underserved populations • NIH started RADx-UP in September 2020, with awards in phases: – Fall 2020: Phase 1 (69 projects) and CDCC – Spring/Summer 2021: SayYes! COVIDTest and the Safe Return to School DiagnosticTesting Initiative (16 projects) – Fall/Winter 2021: Phase 2 (21 projects) and Supplemental (21 projects) – Fall 2022: Additional Phase 3 projects expected • RADx-UP projects build on existing community-academic infrastructure, processes, and relationships
  • 4. Take home messages • The RADx-UP Coordination and Data Collection Center (CDCC) is a joint collaboration of DCRI, UNC Chapel Hill, and the Community-Campus Partnerships for Health. Started in September 2020. • RADx-UP CDCC leverages the Secure Duke Azure Cloud • We coordinate 135+ NIH funded projects and 40 funded pilot projects • We are partnering with many communities throughout the country and use data to drive and enhance those relationships • Meetings: weekly with every project, project-wide every month, NIH every two weeks, working groups, committees, hold scientific meetings, and organize an annual equity evidence academy meeting
  • 5. 5 Program Overview  Phase I: Established a consortium of community-engaged research projects focused primarily on increasing access to and uptake of COVID-19 diagnostic testing  Phase II: Expanded Phase I infrastructure, built in projects with an emphasis on interventions, including a specific focus on school settings, and incorporated research to address vaccine hesitancy and uptake  Target Population: populations with health disparities, underserved and vulnerable groups Overarching Goal The overarching goal of RADx-UP is to understand factors that have led to the disproportionate burden of the pandemic on underserved populations, so that COVID- 19 testing interventions can be developed and implemented to decrease these disparities. RADx-UP Phase I and II
  • 6. RADx-UP Phase III Leverage rapid, self- administeredCOVID-19 testing to understand and address COVID-19 morbidity and mortality disparities among the underserved and vulnerable populations, given the availability of COVID-19 vaccines Study secondary impacts of mandates for mitigation measures associated with COVID-19 and support psychological and communication science interventions to improve uptake of testing and vaccination Expand the evidence base of scalable and sustainable approaches to safely maintain students in school. Integrate new “Test-to-Stay” models that reduce or avoid quarantine and disruptions to the school environment TESTING SEBI SAFE IN SCHOOL Goal: Address the evolving challenges of the pandemic with a focus on developing rapid testing strategies for use with other mitigation efforts (e.g., vaccination, physical mitigation measures) to reduce COVID-19 disparities.
  • 7. Course of the Pandemic in the US
  • 8. Case Rates for Vulnerable Populations CDC COVID Data Tracker Race/Ethnicity https://covid.cdc.gov/covid-data-tracker/#demographicsovertime alpha delta omicron
  • 9. Death Rates for Vulnerable Populations CDC COVID Data Tracker Race/Ethnicity https://covid.cdc.gov/covid-data-tracker/#demographicsovertime alpha delta omicron
  • 10. 10 RADx-UP CDCC Goals Accelerate COVID-19 community implementation implementation science via an agile, flexible, flexible, participatory, transparent and sustainable sustainable CDCC. Support data collection, integration, and integration, and sharing while preserving preserving necessary data protections. Amplify and disseminate community best practices practices for successful implementation of COVID- COVID-19 testing strategies and vaccines. Utilize RADx-UP infrastructure to support COVID-19 research.
  • 11. 11 Sept – Nov 2020 Phase I Phase II Build infrastructure Rapidly implement testing, other capabilities Integrate new advances Investigate social, ethical, & behavioral barriers to testing RADx-UP Phases and Timeline Phase III Expand studies/ populations 2022 Overarching Goals  Enhance COVID-19 testing among underserved and vulnerable populations across the US  Develop/create a consortium of community-engaged research projects designed to rapidly implement testing interventions  Strengthen the available data on disparities in infection rates, disease progression and outcomes, and identify strategies to reduce these disparities in COVID-19 diagnostics  Through better testing, RADx-UP will help researchers see a clearer picture of how COVID-19 affects these populations and how to improve health outcomes around the virus  Expand the evidence base of scalable and sustainable approaches to safely maintain students in school Emphasis on Rapid Testing and Testing in Schools Jan – Nov 2021 School based studies
  • 12. Communities Served by RADx-UP Projects
  • 13. 13 Communities served by RADx-UP projects Self-reported data reflects RADx-UP Phase I and II projects as of 10/20/2021
  • 14. 14 The RADx-UP Coordination and Data Collection Center (CDCC)  The CDCC serves as a hub for all RADx-UP funded projects.  The CDCC supports RADx-UP projects to optimize engagement, outreach, testing strategies, data collection and integration, and co-learning opportunities between and among project teams and to the communities that we serve.  The CDCC is led by the Duke Clinical Research Institute (DCRI), and the Center for Health Equity Research at UNC-Chapel Hill with support from a key partner, Community-Campus Partnerships for Health.
  • 15. 15  RADx-UP is the largest single NIH investment in understanding the factors that protect or harm underserved communities.  RADx-UP projects are required to collect the NIH RADx-UP Common Data Elements (CDEs) in order to capture consistent data for comparison across studies.  The CDCC supports projects in aligning your activities with requirements to make data findable, accessible, interoperable and reusable (FAIR).  The RADx-UP aggregated data will be a resource for NIH, communities, and researchers to understand the impact of COVID-19 on the well-being, risk, resilience, and disparities in underserved and vulnerable communities. NIH Vision for RADx-UP Data
  • 16. The RADx-UP Coordination and Data Collection Center (CDCC) Al Richmond, MSW Community Engagement Core Community-Campus Partnerships for Health Susan Knox, MBA CDCC Program Manager Chris Woods, MD COVID-19 Testing Core Michael Cohen- Wolkowiez, MD, PhD Duke Clinical Research Institute (DCRI) Principal Investigators Giselle Corbie, MD, MSc UNC Center for Health Equity Research Warren A. Kibbe, PhD, FACMI Duke Department of Biostatistics and Bioinformatics Core Leaders 100+ operational & support staff - Experienced - Diversity of backgrounds and training - Dedicated Engagement Impact Teams Keith Marsolo, PhD Data Science & Biostatistics Core Lisa Wruck, PhD Data Science & Biostatistics Core Krista Perreira, PhD Community Engagement Core Operations Key Partner Al Richmond, MSW Community-Campus Partnerships for Health
  • 17. 17 RADx-UP CDCC - Guiding Principles Communities are at the center of our work. Data sovereignty protections, and sharing with communities and participants, are essential in building trust and being trustworthy. Intentional support of study teams is critical to streamline results and troubleshoot. Broad dissemination of program activities, data, and best practices are key. Strategic partnerships will augment community benefits from the program. Impact will be broad and will inform national guidance, strategy, and response to COVID-19.
  • 18. 18 Administration & Coordination  Communication  Committee oversight  Processes, policies, procedures  Partnerships  Evaluation Community Engagement  Best practices  Engagement Resource Library  COVID-19 Equity Evidence Academy  Community of Practice  Community Collaboration Grants COVID-19 Testing  Technical support  Repository of emerging technologies  Testing selection & implementation  Research pilot studies Data Science & Statistics  Data harmonization  Security, privacy, and protections  Data exchange  Data representation and visualization ENGAGEMENT IMPACT TEAMS CDCC Cores
  • 19. RADx-UP CDCC Engagement ImpactTeams • Single point-of-contact between CDCC and project teams with project management & community engagement support – Coordinating testing, community engagement, and data collection and sharing resources – Identifying challenges, collaboratively generating solutions, sharing best practices – Collecting required forms (data use agreements, IRB-approved Informed Consent Forms, etc.) – Connecting projects with translation services – Monitoring progress
  • 20. How CDCC and NIH collaborate to support projects CDCC Engagement ImpactTeams • The primary point of contact at CDCC for each RADx-UP project • Community engagement and project management NIH Project Officers & Scientists • Support in data forms and grant-related questions • First point of escalation CDCC Informaticists • Coordinate data uploads by projects • Perform quality reviews of project data uploads • EIT and PO/PS relationships are critical to RADx-UP success • EITs copy POs on messages to projects • POs include EITs in communications to projects • When escalation is necessary, EIT engages PO to facilitate
  • 21. RADx-UP CDCC Community Engagement • To date – 450+ participants at COVID-19 Equity Evidence Academy events – 20+ best practices/guidance documents – 23 community collaboration grants – 5+ channels for Community of Practice: Slack, newsletters, meetings, CCPH consults, working groups • Key CDCC lesson for this and future pandemics – Deploying community-engaged projects during a pandemic requires robust, trusted, and effective research-community partnerships
  • 22. RADx-UPWorking Groups • RADx-UP projects meet to tackle topics and challenges that may commonly occur among similar populations across the country • Recently added: Social, Ethical and Behavioral ImplicationsWorking Group is gr7306@comcast.net.
  • 23. Project publications on RADx-UP.org Highlighting RADx-UP publications with research briefs, blog posts, video explainers, and more
  • 24. RADx-UP Resources • CDCC continues to collect and create resources for community-engaged researchers and community partners • 132 resources in the collection • Search by – Audience – Topic – Resource type • Start at https://radx-up.org/resources/RADx-UP
  • 25. Strategies from the RADx-UP Initiative • A new policy framework based on experiences from RADx-UP project teams • Identifies 5 key actions to address health inequities in COVID-19 and beyond • Learn more at https://radx-up.org/research/health-equity- framework/
  • 26. Analysis Concepts & Proposals • Initiative to support the preparation of collaborative research articles and presentations that analyze RADx-UP data. • Consortium members are collaborating in writing teams with CDCC statistical support. • Their publications will help community leaders and policy makers identify effective strategies for reducing disparities in COVID- 19 testing and addressing other health needs of their communities.
  • 27. 2021 MAY OCT NOV DEC JAN FEB MAR APR SEP JUN 2022 RADx-UP Key Milestones: Sept. 2021–June 2022 12/2021 Launch of RADx-UP Colectiv data capture tool 12/1/2021 NEW Community Consultation Studio Sessions 1 4 1 2 4 10/2021 RADx-UP Data Quality Resolution Policy and Process 1/20/2022 Guidance and Testing Information re: Delta/Omicron surges Launch of RADx-UP Community Connections Series 10/21/2021 RADx-UP Scientific Meeting 11/2021 Guidance and Testing Information re Ellume home test recall NIH RADx-UP CDEs v1.2 in Spanish 11/17–11/18/2021 RADx-UP COVID-19 Equity Evidence Academy 11/18/2021 You & Me COVID-Free Program 1 2 3 4 1 2 3 4 1 2 3 4 1 3 1 2 4 1 2 4 1 4 1 2 3 1/2022 RADx-UP Image Bank Orientation Session 1 2 5/16/2022 RADx-UP Partnering for Impact 1 4 5/11/2022 RADx-UP Health Equity Policy Framework 1 2 3 4 5/3/2022 RADx-UP Scientific Meeting 1 2 3 4 4/6/2022 NIH RADx-UP CDEs v1.5 1 4 2/3/2022 Webinar: A Community Engaged Approach to COVID-19 Testing in African-American Churches 1 2 3 4 2/14/2022 CDCC New Project Orientation Session 1 2 3 4 2/17/2022 Engaging Black/ African American Working Group virtual town hall 1 2 3 4 2/28/2022 67 projects uploaded CDE data to CDCC 4 3/10/2022 RADx-UP Data Dashboard 1 4 3/17/2022 RADx-UP Area-Level Data Linkage Dashboard 1 4 3/25/2022 RADx-UP.org Redesign 1 2 3 4 Create a community-centered, flexible program infrastructure. Support a participatory and inclusive community engagement program. Support research projects with COVID-19 testing guidance and emerging science. Collect, harmonize, integrate and disseminate data to scientific and local communities. SPECIFIC AIMS: 1 2 3 4 4/7/2022 First Data Transfer to RADx Data Hub (data from 2 projects) 4 6/9/2022 Second Transfer to RADx Data Hub (data from 53 projects) 4 ⭐️ ⭐️ ⭐️ ⭐️
  • 28. Data as of 10/18/2022 at a glance 49 CommunityCollaboration Mini Grants 127 COVID-19 testing and SEBI projects 113 Published research articles 56 States, territories, and D.C. 1 Coordination & Data Collection Center >319,000 Enrolled participants (prospectively) 16 Rapid Research Pilot Awards 86 Projects submitting CDEs to CDCC >389,000 COVID-19 tests conducted (prospectively)
  • 29. 29 Key Outcomes per Target Population (Testing + SEBI) Schools  Participation in weekly testing increases conscious mitigation behavior  When mitigation strategies are followed, in-school transmission is low (<1%) Black and Latino Communities  Latino populations present with greater proportions of asymptomatic cases as compared to national average  Black/African Americans in rural areas have lower testing rates, biasing positivity rates  Black and Latino community populations display greater vaccine hesitancy – Local leaders should be engaged to facilitate acceptance and uptake Lower Socioeconomic Status  Lower income populations have reduced motivation to self-test and distribute testing kits to contacts
  • 30.
  • 31. Common Data Elements Development, Evolution, Implementation and Lessons Learned
  • 32. CDE Development • Oct. 9, 2020: NIH’s RADx-UP Data Harmonization Guidance received by CDCC, which included the original RADx-UP Common Data Elements • Oct. 16, 2020: CDCC team met with the DR2 team to discuss coordination and the CDEs • Based on initial discussions with NIH RADx-UP leadership, it became clear that the original CDEs needed to be modified to meet the project and pandemic circumstances: – Staff and participants were practicing social distancing, with masks – Vaccines were in development but not yet available – Moving into winter 2020, with a surge in cases and deaths expected – Many of the Projects had finalized their protocols and were awaiting IRB approval • CDEs needed to collect key data while also limiting risk and burden for the participants and Project teams
  • 33. CDE Development • Oct. & Nov. 2020: CDCC and NIH worked to revise and pare down the number of CDEs • Dec. 3, 2020: draft version of the CDEs shared with the projects RADx-UPCDE Categories • Sociodemographics and consent • Housing, Employment and Insurance • Medical History • Medications • Symptoms • Health Status (includingAlcohol andTobacco) • Disability • Vaccine Hesitancy • Identity
  • 34. CDE Development • Dec. 8, 2020: CDE Feedback survey sent to the Projects • Dec 14, 2020: Deadline for Projects to complete the survey • Dec. 15, 2020: CDCC reviewed and consolidated feedback and recommendations • Dec. 17, 2020: RADx-UP Project-wide Meeting at which CDE feedback was discussed
  • 35. 13 52 Feedback Survey Questions and Results (Dec 2020) 31 10 7 8 25 9 8 19 18 22 42 8 0 5 10 15 20 25 30 35 40 45 Identity Consent Symptoms (COVID-19) Demographics Disability Employment Health Insurance Health Status Housing Medical History Medications Vaccine Hesitancy Which category or categories contain questions you anticipate not being able to collect?
  • 36. CDE Development • Dec. 18, 2020 – Jan. 2021: CDCC and NIH incorporate Project feedback and finalize the CDEs. Major changes included: – Ethnicity (subcategories added for Asian, Native Hawaiian/Pacific Islander, and Hispanic), – Sexual orientation and gender identity questions added and terminology better aligned with communities – Housing questions clarified and made more relevant to RADx-UP populations – Employment questions made more relevant to COVID-19 pandemic conditions – Health insurance question expanded to include type of insurance – COVID-19 pandemic-related questions added (hardship, PPE, distancing, COVID testing, COVID symptoms, vaccine acceptance) – Spoken language questions added – Medical history questions focused on items relevant to COVID-19 – Medications, vaccine hesitancy, and most of the disability and alcohol/tobaccos questions were moved toTier 2. Sources of these CDEs included PhenX, DR2, NIH CDE Repository, and the RADx-UP Projects
  • 37. Tier 1 CDEs Required from all testing Projects • Consent • Location (new) • Sociodemographics • Housing, Employment and Insurance • Work PPE and Distancing (new) • Medical History • Health Status • VaccineAcceptance • Testing (new) • COVIDTest (new) • Symptoms • Alcohol &Tobacco • Identity Tier 2 CDEs Recommended additionalCDEs • Sociodemographics • Medical History • VaccineAcceptance • Testing • Medications • Alcohol andTobacco • Drug Use • Disability • Food Insecurity • Housing • Trust • Identity – SSN and MRN • Two components: • CDEs recorded by the participants or Project teams • CDEs recorded by the Project teams • Available as REDCap codebook PDF or CSV data dictionary, or PDF forms for paper data collection
  • 38. CDE Development • Jan. 4, 2021: CDEs v.1.0 released to the Projects and made publicly available on RADx-UP.org • Feb. 9-17, 2021: NIH CDETracking Form released, which the Projects could use to request individual or group CDE exceptions and wording changes. • Feb. 2021: CDCC’s Data Submission Guidance document v1.0 released. • EITs and Informaticists began training and providing support for CDE implementation.
  • 39. CDE Revisions Version Release Date Major Changes 1.1 Aug. 12, 2021 Wording, responses, and branching logic fixes 1.2 Sep. 28, 2021 Added vaccine acceptance and administration questions 1.3 Incorporated into 1.4 1.4 Feb. 9, 2022 Added “prefer not to answer” to more questions, existing CDEs modified for pediatric use, and new Pediatric CDEs 1.5 Apr. 6, 2022 Wording, responses, and branching logic fixes 1.6 Oct. 27, 2022 Additional disability questions moved toTier 1 Any new or revisedTier 1 CDEs are only required for projects that were awarded after the CDE release date
  • 40. CDE Intake and Quality Checks • The REDCap codebooks along with the NIH CDE Tracking Form have been the basis around which we have built our repository, data quality and conformance checks, reporting and dashboards, and analysis datasets. • Projects upload their data through our portal (myRADx-Uphome) and get immediate, detailed data quality reports that they use to identify and resolve issues in their CDE data.
  • 41. RADx-UP Data Intake Status • As of Nov 1, 2022: – 99 Projects have uploaded CDE data files – 641,404 participants’ data in our database (not including EHR data) – Using 5,310 project participants’ zip codes, the CDCC has linked to external social determinants of health datasets: Area deprivation index (ADI) Agency for Healthcare Research and Quality (AHRQ) SocialVulnerability Index (SVI) ChildOpportunity Index (COI) PandemicVulnerability Index (PVI) Minority Health SVI vaccination data from cdc.gov
  • 42. Benefits of the RADx-UP CDEs • The CDEs allowed for accelerated intake, harmonization, and use of data: – January 2021: CDEs released – March 2021: First data upload to CDCC – March 2022: RADx-UP Data Dashboard launched (visualizations using CDE data) – April 2022: First data upload from CDCC to the RADx Data Hub – September 2022: Core Analytic Datasets available usingTier 1 CDE data – October 2022: First consortia datasets delivered to writing team for analysis • For the most part, projects were able to quickly understand and resolve data quality and conformance issues. After a few uploads the number of data issues drop significantly. • We have given all newer versions of a CDE its own identifier, so we can trace exactly which version of a CDE was given to a participant and allow projects to update to new versions of the CDEs on their own timeline.
  • 43. 43 To date: •NIH, CDCC, and RADx-UP (Phase I) projects collaborated to develop the NIH RADx-UP Common Data Elements, from 700+ → 60+ •Currently, 99 projects are transferring study data and RADx-UP NIH CDEs to the CDCC data repository •CDE Dashboard provides a window to the aggregated data, will inform consortium publications Key CDCC lesson for this and future pandemics •Developing CDEs during a pandemic is challenging •Engaging projects and community partners is critical to success RADx-UP CDCC Data Science & Biostatistics Core
  • 45. CDE Utilization: RADx-UP CDE Data Dashboard This Dashboard is an example of what’s been possible using the harmonized CDE data.
  • 47. RADx-UP CDE Data Journey
  • 48. CDE and Data ManagementTakeaways • For community-engaged research, bidirectional communication and collaboration between researchers, communities, and participants helps with understanding, acceptance, and uptake of CDEs • Collaboration also ensures that the CDEs accurately reflect the people and communities who are taking part in the research • Participant and study staff burden and risk are important concerns for data collection in a pandemic • CDEs are the foundation – however ingesting data from multiple independent projects with many different experimental designs and scientific goals still requires robust data quality and conformance training, education, monitoring, and review processes
  • 49. • For encouraging testing and vaccination, culturally appropriate education is important to increase trust in official sources of COVID-19 information • Community Advisory Boards have provided key recommendations and support • Community engagement and trust are essential to ensure the success of COVID-19 testing and vaccination programs • Flexibility and the ability to adapt is critical • Partnerships with community health clinics provide a necessary connection to underserved populations Lessons Learned for Future Success

Editor's Notes

  1. Rapid Acceleration of Diagnostics - Underserved Populations
  2. The data is easy to follow on the website: https://covid.cdc.gov/covid-data-tracker/#demographicsovertime This shows the hospitalization rate: https://covid.cdc.gov/covid-data-tracker/#covidnet-hospitalization-network The Urban vs. Rural breakdown and the child hospitalization rate: https://covid.cdc.gov/covid-data-tracker/#pop-factors_7daynewcases
  3. The data is easy to follow on the website: https://covid.cdc.gov/covid-data-tracker/#demographicsovertime This shows the hospitalization rate: https://covid.cdc.gov/covid-data-tracker/#covidnet-hospitalization-network The Urban vs. Rural breakdown and the child hospitalization rate: https://covid.cdc.gov/covid-data-tracker/#pop-factors_7daynewcases
  4. CDCC supports over 88 research projects touching all states and U.S. territories
  5. CDCC supports over 88 research projects touching all states and U.S. territories
  6. EITs and PO/PS relationship: EITs eager to work closely with PO to support project teams Project Orientation: Attend orientation to understand expectations, roles, and get to know your project team via breakout sessions Project’s progress: Be included in EIT emails to projects and project meetings to stay abreast of project’s progress Project Communication: PO’s to include EITs in their communication - CDE exemption status letter First point of escalation when project team needs additional support to resolve challenges
  7. 127 total RADx-UP projects: Phase I (69), Phase II (37), Supplemental (21) Enrolled participants source: CDE data COVID-19 tests conducted source: CDE data Territories include sites in Guam, American Samoa, Northern Mariana Islands, US Virgin Islands, and Puerto Rico
  8. Giselle
  9. Please note that the presentation is only focused on CDEs. Third box: CDE data collection
  10. Susan Courtney ends meeting